[go: up one dir, main page]

NO996492L - Oppløsningsdoseringsformer av sertralin innkapslet i gelatin - Google Patents

Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Info

Publication number
NO996492L
NO996492L NO996492A NO996492A NO996492L NO 996492 L NO996492 L NO 996492L NO 996492 A NO996492 A NO 996492A NO 996492 A NO996492 A NO 996492A NO 996492 L NO996492 L NO 996492L
Authority
NO
Norway
Prior art keywords
sertraline
gelatin
encapsulated
dosage forms
solution dosage
Prior art date
Application number
NO996492A
Other languages
English (en)
Other versions
NO996492D0 (no
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996492(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996492D0 publication Critical patent/NO996492D0/no
Publication of NO996492L publication Critical patent/NO996492L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO996492A 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin NO996492L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (2)

Publication Number Publication Date
NO996492D0 NO996492D0 (no) 1999-12-27
NO996492L true NO996492L (no) 2000-02-29

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996492A NO996492L (no) 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Country Status (40)

Country Link
EP (1) EP0980241B1 (no)
JP (1) JP3585245B2 (no)
KR (1) KR100371730B1 (no)
CN (1) CN1261792A (no)
AP (1) AP945A (no)
AR (1) AR015916A1 (no)
AT (1) ATE256457T1 (no)
AU (1) AU724635B2 (no)
BG (1) BG103917A (no)
BR (1) BR9809712A (no)
CA (1) CA2290973C (no)
CO (1) CO4940405A1 (no)
DE (1) DE69820608T2 (no)
DK (1) DK0980241T3 (no)
DZ (1) DZ2544A1 (no)
EA (1) EA001905B1 (no)
ES (1) ES2210760T3 (no)
GT (1) GT199800090A (no)
HR (1) HRP980378B1 (no)
HU (1) HUP0002250A3 (no)
ID (1) ID24673A (no)
IL (1) IL133075A0 (no)
IS (1) IS5266A (no)
MA (1) MA24586A1 (no)
MY (1) MY119728A (no)
NO (1) NO996492L (no)
NZ (1) NZ501252A (no)
OA (1) OA11246A (no)
PA (1) PA8454001A1 (no)
PE (1) PE97299A1 (no)
PL (1) PL337807A1 (no)
PT (1) PT980241E (no)
SK (1) SK282914B6 (no)
TN (1) TNSN98123A1 (no)
TR (1) TR199903282T2 (no)
TW (1) TW382597B (no)
UA (1) UA68350C2 (no)
UY (1) UY25070A1 (no)
WO (1) WO1999001113A1 (no)
ZA (1) ZA985709B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348119A1 (en) * 1998-10-13 2002-05-06 Pfizer Prod Inc Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
EP1556000A1 (en) * 2002-10-31 2005-07-27 Alza Corporation Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
GB2630572A (en) 2023-05-29 2024-12-04 Novumgen Ltd An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525847T2 (de) * 1994-09-19 2002-09-05 Dupont Pharmaceuticals Co., Wilmington Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DE69626916T2 (de) * 1995-07-17 2003-10-09 Pfizer Inc., New York Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Also Published As

Publication number Publication date
KR20010013588A (ko) 2001-02-26
MA24586A1 (fr) 1998-12-31
OA11246A (en) 2002-11-19
EP0980241A1 (en) 2000-02-23
HRP980378B1 (en) 2001-12-31
PE97299A1 (es) 1999-10-13
IL133075A0 (en) 2001-03-19
HUP0002250A2 (hu) 2000-12-28
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
HRP980378A2 (en) 1999-04-30
PL337807A1 (en) 2000-09-11
TNSN98123A1 (fr) 2005-03-15
EA001905B1 (ru) 2001-10-22
EP0980241B1 (en) 2003-12-17
AP945A (en) 2001-02-28
TR199903282T2 (xx) 2000-08-21
CA2290973A1 (en) 1999-01-14
KR100371730B1 (ko) 2003-02-07
DE69820608D1 (de) 2004-01-29
TW382597B (en) 2000-02-21
HUP0002250A3 (en) 2001-01-29
EA199900963A1 (ru) 2000-08-28
AU724635B2 (en) 2000-09-28
BR9809712A (pt) 2000-07-11
ID24673A (id) 2000-07-27
DZ2544A1 (fr) 2003-02-08
NZ501252A (en) 2004-11-26
AR015916A1 (es) 2001-05-30
ZA985709B (en) 2000-01-10
ES2210760T3 (es) 2004-07-01
PT980241E (pt) 2004-03-31
JP3585245B2 (ja) 2004-11-04
BG103917A (bg) 2000-07-31
ATE256457T1 (de) 2004-01-15
SK282914B6 (sk) 2003-01-09
NO996492D0 (no) 1999-12-27
DK0980241T3 (da) 2004-04-05
IS5266A (is) 1999-11-23
CO4940405A1 (es) 2000-07-24
CN1261792A (zh) 2000-08-02
AP9801279A0 (en) 1998-06-30
CA2290973C (en) 2003-06-17
PA8454001A1 (es) 2000-05-24
MY119728A (en) 2005-07-29
UY25070A1 (es) 2000-12-29
GT199800090A (es) 1999-12-21
SK180599A3 (en) 2001-01-18
DE69820608T2 (de) 2004-12-23
AU7545098A (en) 1999-01-25
WO1999001113A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
DE69829139D1 (de) Medikator vom ansangtyp
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
ATE438305T1 (de) Verkapselung von komponenten in essbaren produkten
NO944046D0 (no) Ökning av medikamentrespons
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
DE69535102D1 (de) Einkapselung von optoelektronischen bauteilen
FI972555L (fi) Päällystettyjen tablettien valmistus
FI934128A7 (fi) Uudenlaisia koteloituja aineita
DE69502726D1 (de) Hestellung von aniontensidgranulaten
ID17794A (id) Bentuk dosis gelatin lunak multi fasa
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
NO996492D0 (no) Opploesningsdoseringsformer av sertralin innkapslet i gelatin
DE69801392D1 (de) Herstellung von Methylchlorid
ATE245415T1 (de) Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe
EA199900672A1 (ru) Гомеопатическое лекарственное средство
DE59812225D1 (de) Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
EA199900673A1 (ru) Гомеопатическое лекарственное средство
DE59807819D1 (de) Duftstoff-enthaltende Zubereitung
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE69811864D1 (de) Herstellung von bandförmigen werkstücken
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
DE69613921D1 (de) Herstellung von Methylaminen
DE59803609D1 (de) Behandlung von Kunststoffoberflächen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application